SEC settles with Columbia-based biotech company over fraud allegations

A Columbia-based biotech company will pay a $1.5 million penalty to settle a Securities and Exchange Commission lawsuit alleging the company and former executives mislead investors. Osiris Therapeutics Inc. did not admit or deny any of the charges in the complaint, filed Thursday in U.S. District Court in Baltimore, but agreed to a final judgment that ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *